HLB생명과학
3,705KRWMarket close of 10/21 (Wed)
Down -2.11%-80KRWMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)3,505KRWDown -5.40%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 3,790
- High
- 3,905
- Low
- 3,700
- Day range
- Day range low 3,700 high 3,905, open 3,790, close 3,705, previous close 3,785
- Volume
- 19×10K shares
- 723.57 million KRW 0.10× the 20-session average
Market close of 10/21 (Wed)
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-22.5B KRWOperating income over the last four quarters -22.5B KRW (loss)
- Daily movenot verifiedOnly 15 daily bars to compare, so not verified
- Trading valuenot verifiedNot enough 20-session trading value data, so not verified
The other 3
- Recent filingsnot verified
- Foreign & institutionalnot verified
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue15.2B KRW
- vs. year ago
- -44.7%
- vs. prior quarter
- Turned profitable
- Operating income-6.5B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-42.5%
- vs. year ago
- -20.9 pp
- vs. prior quarter
- —
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.